(Q36773474)

16 August 2017

1 reference

title

Prediction and prevention of type 1 diabetes: progress, problems, and prospects (English)

1 reference

16 August 2017

0 references

1

Skyler JS

1 reference

16 August 2017

language of work or name

English

0 references

publication date

28 March 2007

1 reference

Clinical Pharmacology & Therapeutics

16 August 2017

published in

1 reference

16 August 2017

volume

81

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

768-771

1 reference

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Type 1 diabetes: recent developments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Can islet cell antibodies predict IDDM in the general population?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Effects of insulin in relatives of patients with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Beta-cell autoantibodies in infants and toddlers without IDDM relatives: diabetes autoimmunity study in the young (DAISY)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type I diabetes: the German BABYDIAB study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Natural history of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Natural history of beta-cell function in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Does partial preservation of residual beta-cell function justify immune intervention in recent onset Type I diabetes?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Cyclosporine in recent onset type I diabetes mellitus. Effects on islet beta cell function. Miami Cyclosporine Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Insulin prophylaxis in individuals at high risk of type I diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Oral tolerance for the treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100179

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100179

1 reference

Dimensions Publication ID

16 August 2017

1053383048

0 references

1 reference